CompletedPhase 4NCT00204373

Treatment of Zollinger-Ellison Syndrome With Prevacid

Studying Zollinger-Ellison syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Charles Mel Wilcox, MD
Principal Investigator
C. Mel Wilcox, M.D.
University of Alabama at Birmingham
Intervention
Lansoprazole (Prevacid)(drug)
Enrollment
72 enrolled
Eligibility
19 years · All sexes
Timeline
2003 – 2010

Collaborators

Takeda Pharmaceuticals North America, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00204373 on ClinicalTrials.gov

Other trials for Zollinger-Ellison syndrome

Additional recruiting or active studies for the same condition.

See all trials for Zollinger-Ellison syndrome →

← Back to all trials